Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SU101 vs Procarbazine in Recurrent Glioblastoma Multiforme
NCT00003293Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 1998
- Primary completion
- May 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of leflunomide in glioblastoma multiforme (GBM), sponsored by Pfizer. Started Feb 1998; status: completed.
02
Drugs
leflunomide
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00003293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003293.